These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24612251)

  • 61. Noninvasive measurement of liver fibrosis by transient elastography and influencing factors in patients with chronic hepatitis B-A single center retrospective study of 466 patients.
    Ding H; Wu T; Ma K; Wang X; Wu Z; Guo W; Qi J; Ning Q
    J Huazhong Univ Sci Technolog Med Sci; 2012 Feb; 32(1):69-74. PubMed ID: 22282248
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?
    Chakrabarty G; Bruce M; Horner M; Wang B; Agarwal K; Carey I
    J Viral Hepat; 2018 Jan; 25(1):80-87. PubMed ID: 28710798
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
    Coco B; Oliveri F; Maina AM; Ciccorossi P; Sacco R; Colombatto P; Bonino F; Brunetto MR
    J Viral Hepat; 2007 May; 14(5):360-9. PubMed ID: 17439526
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
    Alam S; Ahmad N; Mustafa G; Shrestha A; Alam AK; Khan M
    Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment Response Monitoring of Chronic Hepatitis B Patients using Transient Elastography and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI).
    Tenggara IR; Lesmana CR; Gani RA
    Acta Med Indones; 2017 Jul; 49(3):220-226. PubMed ID: 29093232
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Body-mass index is associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B.
    Seto WK; Fung J; Cheung KS; Mak LY; Hui RW; Liu KS; Lai CL; Yuen MF
    Aliment Pharmacol Ther; 2016 Nov; 44(10):1071-1079. PubMed ID: 27659292
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B.
    Ji D; Chen Y; Shang Q; Liu H; Tan L; Wang J; Chen Y; Li Q; Long Q; Song L; Jiang L; Xiao G; Yu Z; Chen L; Hu X; Wang X; Chen D; Li Z; Dong Z; Chen G; Yang Y
    Am J Gastroenterol; 2021 Aug; 116(8):1676-1685. PubMed ID: 33840727
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study.
    Hui RWH; Seto WK; Cheung KS; Mak LY; Liu KSH; Fung J; Wong DK; Lai CL; Yuen MF
    J Viral Hepat; 2018 Jan; 25(1):97-104. PubMed ID: 28772340
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkers.
    Liang XE; Zhong C; Huang L; Yang S; Zhu Y; Chen Y; Hou J
    J Gastroenterol Hepatol; 2017 Feb; 32(2):459-465. PubMed ID: 27346683
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).
    Poynard T; Vergniol J; Ngo Y; Foucher J; Thibault V; Munteanu M; Merrouche W; Lebray P; Rudler M; Deckmyn O; Perazzo H; Thabut D; Ratziu V; de Ledinghen V;
    J Hepatol; 2014 Nov; 61(5):994-1003. PubMed ID: 25016224
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis.
    Fung J; Lai CL; Chan SC; But D; Seto WK; Cheng C; Wong DK; Lo CM; Fan ST; Yuen MF
    Am J Gastroenterol; 2010 May; 105(5):1116-22. PubMed ID: 19920809
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).
    Jung KS; Kim SU; Ahn SH; Park YN; Kim DY; Park JY; Chon CY; Choi EH; Han KH
    Hepatology; 2011 Mar; 53(3):885-94. PubMed ID: 21319193
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis.
    Kim MN; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Song KJ; Park YN; Han KH
    Hepatology; 2015 Jun; 61(6):1851-9. PubMed ID: 25643638
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response.
    Charatcharoenwitthaya P; Pongpaibul A; Kaosombatwattana U; Bhanthumkomol P; Bandidniyamanon W; Pausawasdi N; Tanwandee T
    Liver Int; 2017 Apr; 37(4):542-551. PubMed ID: 27740738
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Performance of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome.
    Wu HM; Sheng L; Wang Q; Bao H; Miao Q; Xiao X; Guo CJ; Li H; Ma X; Qiu DK; Hua J
    World J Gastroenterol; 2018 Feb; 24(6):737-743. PubMed ID: 29456412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.